The decreased wnt5a level observed in patients with onset T2DM in this study may suggest that changes in the wnt5a level represent a regulatory mechanism to counteract metabolic stress and β cell dysfunction in diabetes. This evidence concerns the gene WNT5A and type 2 diabetes mellitus.